Halozyme Therapeutics shares owned by Centerpoint Advisors
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Centerpoint Advisors
from 13F filings
Historical chart of Centerpoint Advisors investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Centerpoint Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Centerpoint Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $40k | 550 | 72.73 |
| 2025-06-30 | $29k | 550 | 52.73 |
| 2025-03-31 | $35k | 550 | 63.64 |
| 2024-12-31 | $26k | 550 | 47.27 |
| 2024-09-30 | $31k | 550 | 56.36 |
| 2024-06-30 | $29k | 550 | 52.73 |
| 2024-03-31 | $22k | 550 | 40.00 |
| 2023-12-31 | $20k | 550 | 36.36 |
| 2023-09-30 | $27k | 700 | 38.57 |
| 2023-06-30 | $25k | 700 | 35.71 |
| 2023-03-31 | $27k | 700 | 38.57 |
| 2022-12-31 | $40k | 700 | 57.14 |
| 2022-09-30 | $42k | 1.1k | 40.00 |
| 2022-06-30 | $46k | 1.1k | 43.81 |
| 2022-03-31 | $42k | 1.1k | 40.00 |
| 2021-12-31 | $44k | 1.1k | 40.00 |
| 2021-09-30 | $45k | 1.1k | 40.91 |
| 2021-06-30 | $50k | 1.1k | 45.45 |
| 2021-03-31 | $46k | 1.1k | 41.82 |
| 2020-12-31 | $47k | 1.1k | 42.73 |
| 2020-09-30 | $29k | 1.1k | 26.36 |
| 2020-06-30 | $29k | 1.1k | 26.36 |
| 2020-03-31 | $20k | 1.1k | 18.18 |
| 2019-12-31 | $20k | 1.1k | 18.18 |
| 2019-09-30 | $17k | 1.1k | 15.45 |
| 2019-06-30 | $19k | 1.1k | 17.27 |
| 2019-03-31 | $18k | 1.1k | 16.36 |
| 2018-12-31 | $16k | 1.1k | 14.55 |
| 2018-09-30 | $20k | 1.1k | 18.18 |
| 2018-06-30 | $19k | 1.1k | 17.27 |
| 2018-03-31 | $22k | 1.1k | 20.00 |
| 2017-12-31 | $22k | 1.1k | 20.00 |